NCT05481892View on ClinicalTrials.gov

Remote Monitoring for Equity in Advancing Control of Hypertension

NAEnrolling by invitationINTERVENTIONAL
Enrollment

540

Participants

Timeline

Start Date

April 20, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

June 30, 2026

Conditions
Hypertension
Interventions
DEVICE

Cellular Home blood pressure (BP) monitoring

Patients receiving intervention will receive cellular home blood pressure (BP) monitoring devices. Some patients will also receive pharmacist support for treatment intervention.

Trial Locations (1)

94110

Zuckerberg San Francisco General Hospital/University of California, San Francisco, San Francisco

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

University of California, San Francisco

OTHER